The complex generic market needs to “achieve parity” with the innovator market, as the number of approvals is lagging the innovator sector and has not achieved its full market potential, said Robert ...

The US Food and Drug Administration’s (FDA) difficulties in approving generic versions of complex products were front and center in Commissioner Scott Gottlieb’s comments at FDA’s Generic Drug Science ...

Complex generics are driving Indian pharma’s high-margin future in 2026: Experts: Shardul Nautiyal, Mumbai Friday, May 15, 2026, 08:00 Hrs [IST] Indian pharmaceutical companies, ...

Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the ...

In his first speech to Congress, President Joe Biden echoed the call for lower prescription drug costs that we have been hearing for many years. Democrats have been eying government negotiated drug ...

Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics ...

Amneal has submitted ANDAs to the Food and Drug Administration for the following three complex generics: Injectable propofol emulsion, the generic version of Diprivan, is an I.V. general anesthetic ...

India business crosses ₹12,680 crore in FY26 as Cipla expands specialty pipeline, respiratory portfolio and regulated market ...

Trelegy Ellipta is a maintenance treatment for patients with asthma and COPD. "The FDA's acceptance of our ANDA filing for ...

MIRAMAR, Fla., April 9, 2026 /PRNewswire/ -- DifGen Pharmaceuticals LLC, a U.S.-based specialty generic pharmaceutical company today announced that its partner, Apotex Inc., has received final ...

Cipla is developing a biosimilars pipeline, with plans to add 1-2 products yearly for the next five years. The drugmaker is ...